Iron Deficiency Anemia of Pregnancy Clinical Trial
Official title:
Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial
Iron deficiency is the most common cause of anemia in pregnancy worldwide, and, when severe, can have serious consequences for mothers and babies. While treatment of iron-deficiency anemia with iron supplementation is recommended, treatment strategies remain controversial: the American College of Obstetrics and Gynecology recommends oral iron supplementation with parental iron reserved for the rare patient who cannot tolerate or will not take oral iron, while UK professional organizations recommend a more liberal use of parenteral iron. The reason for these disparate recommendations is that few high-quality studies comparing oral to parenteral iron have been conducted in developed countries, and the potential impact of parental iron treatment on obstetric and perinatal outcomes remains unclear. We propose the first randomized-controlled trial in the United States describing the effectiveness and safety of treating pregnant women with iron-deficiency anemia with a protocol including parenteral iron compared with a protocol based on oral iron.
Iron deficiency is the most common cause of anemia in pregnancy worldwide, and, when severe,
can have serious consequences for mothers and babies. In the U.S., anemia affects nearly 20%
of pregnancies and the majority is iron-deficiency anemia. Therefore, treatment of
iron-deficiency anemia with iron supplementation is recommended.1 However, there is
controversy about the treatment strategies.
The American College of Obstetrics and Gynecology recommends oral iron supplementation for
iron-deficiency anemia in pregnancy, with parental iron reserved only for the "rare patient
who cannot tolerate or will not take oral iron" (1) Conversely, guidelines from the U.K. are
more liberal on the use of parental iron for the treatment of iron-deficiency anemia in
pregnancy (2). Both treatment guidelines are based on limited data regarding the risks and
benefits of parental iron for treatment of iron-deficiency anemia in pregnancy. The majority
of randomized trials were conducted in developing country settings. In fact, few high-quality
studies have been conducted in developed countries, and none has been conducted in the U.S.
Moreover, there is limited data from prior studies on the impact of parental iron treatment
on perinatal outcomes. The most recent Cochrane review including mostly from trials conducted
in low-income countries found that, although parenteral iron improved hemoglobin levels and
iron stores than the oral route, no clinical outcomes were assessed and there were
insufficient data on adverse effects (3). The authors concluded that "large, good quality
trials, assessing clinical outcomes including adverse effects … are required" (3).
This randomized controlled trial aims to assess the effectiveness and safety of treating
pregnant women with iron-deficiency anemia with a protocol including parenteral iron compared
with a protocol based on oral iron. We hypothesize that treating iron-deficiency anemia with
parental iron is associated with improved maternal and neonatal outcomes compared with a
protocol based on oral iron. To increase generalizability of the findings, we will use broad
inclusion criteria and analyze data using the intention-to-treat principle.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03456258 -
Lactoferrin Versus Ferrous Sulphate for the Treatment of Iron Deficiency Anemia During Pregnancy
|
N/A | |
Not yet recruiting |
NCT04074707 -
Defining a Dosing Regimen With Maximal Absorption for Oral Iron Supplementation During Pregnancy
|
N/A | |
Completed |
NCT03481790 -
Lactoferrin Versus Ferrous Sulphate for Treatment of Iron Deficiency Anaemia During Pregnancy
|
Phase 2 | |
Terminated |
NCT04594070 -
Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in Pregnancy
|
Phase 4 | |
Completed |
NCT03706638 -
Daily vs Intermittent Iron Therapy in Pregnancy
|
N/A | |
Recruiting |
NCT06366698 -
Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia
|
Phase 3 | |
Not yet recruiting |
NCT03484845 -
Lactoferrin Versus Ferrous Fumarate for Treatment of Mild to Moderate Iron Deficiency Anemia During Pregnancy
|
Phase 1/Phase 2 | |
Recruiting |
NCT03961074 -
Iron Deficiency Anemia Among Chinese Pregnant Women: a Multi-center Prospective Cohort Study
|
||
Recruiting |
NCT05804071 -
Analysis of the Effect of Iron Supplements on Iron Deficiency Anemia in Pregnancy
|
Phase 4 | |
Recruiting |
NCT04008147 -
Hepcidin and Glucose Metabolism
|
N/A | |
Completed |
NCT03188445 -
Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.
|
Phase 4 | |
Completed |
NCT05157828 -
Iron Deficiency Anaemia in Pregnant Patients Presenting for Antenatal Care
|
||
Active, not recruiting |
NCT05545527 -
Neuroimaging Ancillary Study
|
||
Completed |
NCT05725278 -
Impact Evaluation of Triggerise's Tiko Platform
|
N/A | |
Completed |
NCT03378791 -
Efficacy of Iron Bisglycinate in Treatment of Iron Deficiency Anemia in Pregnant Women
|
Phase 3 | |
Completed |
NCT02005588 -
Treatment of Iron Deficiency Anemia With Pregnancy
|
Phase 0 | |
Completed |
NCT03657433 -
Intravenous Infusions of Ferumoxytol Compared to Oral Ferrous Sulfate for the Treatment of Anemia in Pregnancy
|
Phase 3 | |
Completed |
NCT04976179 -
Iron Infusion Into a Vein Compared to Iron Tablet Taken by Mouth for Treating Iron Deficiency Anemia in Pregnancy (IVON)
|
Phase 3 | |
Available |
NCT05151679 -
Chelated Oral Iron Versus Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia Late in Pregnancy
|